Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Plunges 6%; BSE HEALTHCARE Index Down 0.8%
Mon, 7 Oct 12:52

INDRAPRASTHA MEDICAL Plunges 6%; BSE HEALTHCARE Index Down 0.8%Image source: DNY59/www.istockphoto.com

INDRAPRASTHA MEDICAL share price has plunged 6% and is presently trading at Rs 398.4.

Meanwhile, the BSE HEALTHCARE index is at 43,195.6 (down 0.8%).

Among the top losers in the BSE HEALTHCARE index today are GSK Pharma (down 4.1%) and SUVEN PHARMACEUTICALS (down 3.9%).

ASTRAZENECA PHARMA (up 3.9%) and Natco Pharma (up 2.5%) are among the top gainers today.

Over the last one year, INDRAPRASTHA MEDICAL has moved up from Rs 175.2 to Rs 398.4, registering a gain of Rs 223.3 (up 127.5%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,428.9 to 43,195.6, registering a gain of 51.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 146.8%), SUVEN PHARMACEUTICALS (up 100.7%) and Glenmark Pharma (up 98.0%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,354.6 (down 0.4%).

The top losers among the BSE Sensex today are MUNDRA PORT & SEZ (down 3.8%) and NTPC (down 3.8%). The most traded stocks in the BSE Sensex are Tata Steel and Axis Bank.

In the meantime, NSE Nifty is at 24,822.7 (down 0.8%). NTPC and MUNDRA PORT & SEZ are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,512.1 to 81,354.6, registering a gain of 15,842.5 points (up 24.2%).

INDRAPRASTHA MEDICAL Financial Update...

INDRAPRASTHA MEDICAL net profit grew 46.8% YoY to Rs 448 million for the quarter ended June 2024, compared to a profit of Rs 305 million a year ago. Net sales rose 13.5% to Rs 3,479 million during the period as against Rs 3,065 million in April-June 2023.

For the year ended March 2024, INDRAPRASTHA MEDICAL reported 43.9% increase in net profit to Rs 1,240 million compared to net profit of Rs 862 million during FY23. Revenue of the company grew 13.3% to Rs 12,447 million during FY24.

The current Price to earnings ratio of INDRAPRASTHA MEDICAL, based on rolling 12 month earnings, stands at 26.4.


Equitymaster requests your view! Post a comment on "INDRAPRASTHA MEDICAL Plunges 6%; BSE HEALTHCARE Index Down 0.8%". Click here!